NCT02495363
- Conditions
- Breast Diseases, Breast Neoplasms, Malignant Neoplasm of Breast, +4 more
- Locations
-
- Rabin Medical Center Petach Tikvah, Israel
Clinical trial condition
Malignant Neoplasm of Breast
Explore clinical trials studying Malignant Neoplasm of Breast. Study availability and eligibility vary by location and protocol.
29 public trials
3 recruiting studies
Malignant Neoplasm of Breast trial results
NCT02378337
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +28 more
- Locations
-
- Hospital Sao Rafael Salvador, Estado de Bahia, Brazil
Active, Not Recruiting
An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer
NCT03429907
- Conditions
- Breast Diseases, Breast Neoplasms, Malignant Neoplasm of Breast, +4 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
NCT02204098
- Conditions
- Breast Cancer, Breast Carcinoma, Breast Diseases, +6 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Active, Not Recruiting
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
NCT03435952
- Conditions
- Breast Diseases, Breast Neoplasms, Female Urogenital Diseases, +22 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Selumetinib and Olaparib in Solid Tumors
NCT03162627
- Conditions
- Breast Diseases, Breast Neoplasms, Malignant Neoplasm of Breast, +8 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
NCT06495164
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Pfizer New York New York, United States
Active, Not Recruiting
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
NCT03379428
- Conditions
- Breast Diseases, Breast Neoplasms, Malignant Neoplasm of Breast, +4 more
- Locations
-
- 10 sites incl TX, WA, VA, and NV Dallas, Texas, United States
NCT05033756
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Department of Gynecology, Tübingen University Hospital Tübingen, Baden-Wurttemberg, Germany
- University Hospital Ulm Ulm, Baden-Wurttemberg, Germany
- Department of Gynecology and Obstetrics, Erlangen University Hospital Erlangen, Bavaria, Germany
- Marienhospital Bottrop Bottrop, North Rhine-Westphalia, Germany